about
Detection of circulating tumor DNA in early- and late-stage human malignanciesDevelopment of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.Implantable diagnostic device for cancer monitoringNuclear matrix proteins as biomarkers for breast cancer.Expression of two basic mRNA biomarkers in peripheral blood of patients with non-small cell lung cancer detected by real-time rt-PCR, individually and simultaneously.The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?The role of surrogate markers in the clinical development of antiretroviral therapy: a model for early evaluation of targeted cancer drugs.Development and use of biomarkers in oncology drug development.TD-GC-MS Investigation of the VOCs Released from Blood Plasma of Dogs with Cancer.Development of a Mammalian suspension culture for expression of active recombinant human urokinase-type plasminogen activator.Use of Biomarkers in Screening for Cancer.Recent advances in tumor markers of human hepatocellular carcinoma.Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens.Tumor markers in clinical practice: a review focusing on common solid cancersMultianalyte immunoassay chip for detection of tumor markers by chemiluminescent and colorimetric methods.Ratiometric Array of Conjugated Polymers-Fluorescent Protein Provides a Robust Mammalian Cell Sensor.Biomarkers for hepatocellular carcinoma.Influence of cardiopulmonary resuscitation on levels of tumour markers.Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.
P2860
Q29615778-AFDBC123-8344-4E85-B9F0-105CF8E55393Q30635373-0C8A06FF-E415-4569-B124-E782482CE7BCQ33445789-DE75A3D0-4B9D-4FE7-A06B-E93B5CBC06D9Q34606945-2747FD5F-F8BC-4CCC-A275-47958E1C5182Q35065394-B6A0B373-0680-4695-AC09-DBB3587A9EDEQ35206311-0B1C2BFA-E11F-4C04-8E84-BB0FFD481F2EQ35740281-D76F8049-16E5-48E8-8126-54D34BD77589Q35812532-3C5567F4-E908-4CF6-A6EF-D92171866690Q35911795-8580EB86-495E-41D5-A2A2-4446EB7AB2C3Q36255134-038D5092-7B94-4F55-B7A9-B5694DEC0EABQ37155019-7C2D71EB-219C-4D04-B679-5124D758D9B6Q37188255-456C3D31-CE84-404F-B62C-F3A5701B08C6Q37398286-0D3FC41F-E8B4-429B-BDD0-5B208EA2F3DCQ38010046-B90488B9-4D05-4CF7-A868-566836095DD6Q39472085-7C03437A-B821-4323-B007-B5E6EE3D4F7BQ50428372-D1EE3B28-BD83-44A1-B1CA-D00C4CC09686Q51595454-0A1D9B6F-B960-4ECF-B16E-9A7D3DA59D17Q51792770-B0E5CB3D-B2B3-4C5E-B521-34BA307426ABQ53140408-D491B8E8-1DC3-4043-962B-8F54B67E0224
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical uses of tumor markers: a critical review.
@ast
Clinical uses of tumor markers: a critical review.
@en
Clinical uses of tumor markers: a critical review.
@nl
type
label
Clinical uses of tumor markers: a critical review.
@ast
Clinical uses of tumor markers: a critical review.
@en
Clinical uses of tumor markers: a critical review.
@nl
prefLabel
Clinical uses of tumor markers: a critical review.
@ast
Clinical uses of tumor markers: a critical review.
@en
Clinical uses of tumor markers: a critical review.
@nl
P2860
P356
P1476
Clinical uses of tumor markers: a critical review.
@en
P2093
P2860
P304
P356
10.1080/20014091084218
P577
2001-06-01T00:00:00Z